Aclaris Therapeutics, Inc 10-K for FY2022
Aclaris Therapeutics, Inc. (ACRS)
10-K
2023-02-23
For: 2022-12-31
View Original
Added on
April 08, 2026
About this 10-K
Aclaris Therapeutics, Inc filed this 10-K on February 23, 2023, covering the fiscal year ended December 31, 2022 (FY2022).
Headline figures
Fiscal year ended December 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $29.75M
- up 340.1% from $6.76M a year earlier
- Net loss
- $86.91M
- compared with a net loss of $90.87M a year earlier
- Diluted EPS
- -$1.33
- compared with -$1.60 a year earlier